Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants

Completed · Phase 2 · Has a placebo group

Conditions studied: Ureaplasma Infections

In brief

The purpose of this study is to determine whether intravenous azithromycin is effective in eradicating Ureaplasma respiratory tract infection in preterm infants born at 24 to 28 weeks gestation.

Key facts

Study ID
NCT01778634
Run by
University of Maryland, Baltimore
People needed
121
Starts
2013-07-01
Expected to finish
2020-11-03
Last updated by the study team
2020-11-30

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.